Geoffrey E. Harris - 18 Nov 2022 Form 4 Insider Report for Vyant Bio, Inc.

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Nov 2022
Net transactions value
-$1,021
Form type
4
Filing time
22 Nov 2022, 15:03:15 UTC
Previous filing
19 Oct 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Sale $133 -99 -0.67% $1.34 14,685 18 Nov 2022 Direct
transaction VYNT Common Stock, $0.0001 par value Sale $888 -666 -4.5% $1.33 14,019 18 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.